Merit Medical Systems, Inc. (MMSI)
USD 97.13
(-1.89%)
USD 97.13
(-1.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 583.87 Million USD | 0.6% |
| 2022 | 519.09 Million USD | 6.96% |
| 2021 | 485.33 Million USD | 20.98% |
| 2020 | 401.17 Million USD | -7.21% |
| 2019 | 432.36 Million USD | 9.52% |
| 2018 | 394.77 Million USD | 21.0% |
| 2017 | 326.25 Million USD | 23.1% |
| 2016 | 265.02 Million USD | 12.4% |
| 2015 | 235.78 Million USD | 4.69% |
| 2014 | 225.22 Million USD | 15.87% |
| 2013 | 194.36 Million USD | 6.8% |
| 2012 | 181.99 Million USD | 9.99% |
| 2011 | 165.46 Million USD | 28.77% |
| 2010 | 128.49 Million USD | 18.1% |
| 2009 | 108.8 Million USD | 16.65% |
| 2008 | 93.27 Million USD | 16.89% |
| 2007 | 79.79 Million USD | 9.19% |
| 2006 | 73.07 Million USD | 5.77% |
| 2005 | 69.09 Million USD | 2.37% |
| 2004 | 67.49 Million USD | 11.14% |
| 2003 | 60.72 Million USD | 25.16% |
| 2002 | 48.51 Million USD | 27.34% |
| 2001 | 38.09 Million USD | 9.03% |
| 2000 | 34.94 Million USD | 3.69% |
| 1999 | 33.7 Million USD | 17.01% |
| 1998 | 28.8 Million USD | 12.94% |
| 1997 | 25.5 Million USD | 8.05% |
| 1996 | 23.6 Million USD | 22.28% |
| 1995 | 19.3 Million USD | 21.38% |
| 1994 | 15.9 Million USD | 21.37% |
| 1993 | 13.1 Million USD | 21.3% |
| 1992 | 10.8 Million USD | 61.19% |
| 1991 | 6.7 Million USD | 179.17% |
| 1990 | 2.4 Million USD | 900.0% |
| 1989 | -300 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 157.53 Million USD | -1.73% |
| 2024 Q2 | 160.31 Million USD | 5.67% |
| 2024 Q1 | 151.71 Million USD | 12.22% |
| 2023 Q2 | 152.78 Million USD | 10.42% |
| 2023 Q3 | 142.19 Million USD | -6.93% |
| 2023 Q4 | 135.19 Million USD | -4.93% |
| 2023 FY | 522.23 Million USD | 0.6% |
| 2023 Q1 | 138.36 Million USD | 2.83% |
| 2022 Q4 | 134.55 Million USD | 4.65% |
| 2022 Q3 | 128.57 Million USD | -4.81% |
| 2022 Q2 | 135.06 Million USD | 11.71% |
| 2022 FY | 519.09 Million USD | 6.96% |
| 2022 Q1 | 120.9 Million USD | -6.13% |
| 2021 Q2 | 124.13 Million USD | 10.94% |
| 2021 Q3 | 120.49 Million USD | -2.94% |
| 2021 Q4 | 128.8 Million USD | 6.9% |
| 2021 FY | 485.33 Million USD | 20.98% |
| 2021 Q1 | 111.89 Million USD | 0.66% |
| 2020 Q1 | 103.78 Million USD | -7.03% |
| 2020 Q3 | 102.01 Million USD | 21.13% |
| 2020 Q4 | 111.16 Million USD | 8.97% |
| 2020 FY | 401.17 Million USD | -7.21% |
| 2020 Q2 | 84.21 Million USD | -18.85% |
| 2019 Q2 | 111.96 Million USD | 7.0% |
| 2019 Q3 | 104.13 Million USD | -6.99% |
| 2019 Q4 | 111.63 Million USD | 7.2% |
| 2019 FY | 432.36 Million USD | 9.52% |
| 2019 Q1 | 104.63 Million USD | -0.03% |
| 2018 FY | 394.77 Million USD | 21.0% |
| 2018 Q2 | 100 Million USD | 13.57% |
| 2018 Q4 | 104.66 Million USD | 2.57% |
| 2018 Q1 | 88.05 Million USD | 2.8% |
| 2018 Q3 | 102.03 Million USD | 2.03% |
| 2017 Q3 | 80.51 Million USD | -4.31% |
| 2017 FY | 326.25 Million USD | 23.1% |
| 2017 Q4 | 85.65 Million USD | 6.39% |
| 2017 Q2 | 84.14 Million USD | 10.8% |
| 2017 Q1 | 75.94 Million USD | 8.09% |
| 2016 Q4 | 70.25 Million USD | 3.6% |
| 2016 Q1 | 60.1 Million USD | -0.34% |
| 2016 Q2 | 66.85 Million USD | 11.24% |
| 2016 Q3 | 67.81 Million USD | 1.44% |
| 2016 FY | 265.02 Million USD | 12.4% |
| 2015 FY | 235.78 Million USD | 4.69% |
| 2015 Q2 | 60.88 Million USD | 9.94% |
| 2015 Q4 | 60.3 Million USD | 1.86% |
| 2015 Q1 | 55.38 Million USD | -7.9% |
| 2015 Q3 | 59.2 Million USD | -2.76% |
| 2014 Q4 | 60.13 Million USD | 4.72% |
| 2014 Q3 | 57.42 Million USD | 3.23% |
| 2014 Q2 | 55.62 Million USD | 6.88% |
| 2014 FY | 225.22 Million USD | 15.87% |
| 2014 Q1 | 52.04 Million USD | -2.47% |
| 2013 Q2 | 46.98 Million USD | 9.29% |
| 2013 FY | 194.36 Million USD | 6.8% |
| 2013 Q4 | 53.35 Million USD | 4.56% |
| 2013 Q1 | 42.99 Million USD | -5.43% |
| 2013 Q3 | 51.03 Million USD | 8.61% |
| 2012 Q3 | 45.33 Million USD | -3.59% |
| 2012 Q4 | 45.46 Million USD | 0.28% |
| 2012 Q2 | 47.02 Million USD | 6.46% |
| 2012 Q1 | 44.17 Million USD | 4.8% |
| 2012 FY | 181.99 Million USD | 9.99% |
| 2011 Q1 | 39.78 Million USD | 9.43% |
| 2011 Q3 | 41.05 Million USD | -3.37% |
| 2011 FY | 165.46 Million USD | 28.77% |
| 2011 Q2 | 42.48 Million USD | 6.78% |
| 2011 Q4 | 42.14 Million USD | 2.66% |
| 2010 FY | 128.49 Million USD | 18.1% |
| 2010 Q2 | 32.45 Million USD | 14.15% |
| 2010 Q3 | 31.24 Million USD | -3.73% |
| 2010 Q4 | 36.35 Million USD | 16.36% |
| 2010 Q1 | 28.43 Million USD | 4.1% |
| 2009 Q4 | 27.31 Million USD | -4.27% |
| 2009 FY | 108.8 Million USD | 16.65% |
| 2009 Q1 | 24.8 Million USD | 5.6% |
| 2009 Q2 | 28.14 Million USD | 13.44% |
| 2009 Q3 | 28.53 Million USD | 1.39% |
| 2008 Q2 | 24.5 Million USD | 13.48% |
| 2008 Q3 | 23.68 Million USD | -3.34% |
| 2008 Q4 | 23.49 Million USD | -0.81% |
| 2008 FY | 93.27 Million USD | 16.89% |
| 2008 Q1 | 21.59 Million USD | -0.1% |
| 2007 Q2 | 19.53 Million USD | 3.6% |
| 2007 Q4 | 21.61 Million USD | 9.25% |
| 2007 FY | 79.79 Million USD | 9.19% |
| 2007 Q1 | 18.85 Million USD | -0.55% |
| 2007 Q3 | 19.78 Million USD | 1.26% |
| 2006 Q1 | 17.05 Million USD | 2.91% |
| 2006 Q2 | 18.99 Million USD | 11.41% |
| 2006 Q3 | 18.06 Million USD | -4.89% |
| 2006 Q4 | 18.96 Million USD | 4.95% |
| 2006 FY | 73.07 Million USD | 5.77% |
| 2005 Q4 | 16.56 Million USD | -1.39% |
| 2005 Q3 | 16.8 Million USD | -7.98% |
| 2005 Q2 | 18.26 Million USD | 4.58% |
| 2005 Q1 | 17.46 Million USD | 1.19% |
| 2005 FY | 69.09 Million USD | 2.37% |
| 2004 Q2 | 18 Million USD | 9.59% |
| 2004 Q3 | 15.79 Million USD | -12.31% |
| 2004 Q4 | 17.25 Million USD | 9.26% |
| 2004 FY | 67.49 Million USD | 11.14% |
| 2004 Q1 | 16.43 Million USD | 0.85% |
| 2003 Q1 | 13.27 Million USD | 3.89% |
| 2003 FY | 60.72 Million USD | 25.16% |
| 2003 Q2 | 15.18 Million USD | 14.39% |
| 2003 Q4 | 16.29 Million USD | 1.98% |
| 2003 Q3 | 15.97 Million USD | 5.25% |
| 2002 Q4 | 12.77 Million USD | 1.73% |
| 2002 Q1 | 11.15 Million USD | 14.65% |
| 2002 Q2 | 12.03 Million USD | 7.9% |
| 2002 Q3 | 12.55 Million USD | 4.35% |
| 2002 FY | 48.51 Million USD | 27.34% |
| 2001 Q3 | 9.72 Million USD | 3.18% |
| 2001 Q4 | 9.72 Million USD | 0.01% |
| 2001 Q2 | 9.42 Million USD | -8.76% |
| 2001 FY | 38.09 Million USD | 9.03% |
| 2001 Q1 | 10.33 Million USD | 20.87% |
| 2000 Q3 | 9.03 Million USD | 4.22% |
| 2000 Q1 | 8.68 Million USD | -7.63% |
| 2000 Q2 | 8.67 Million USD | -0.1% |
| 2000 Q4 | 8.54 Million USD | -5.44% |
| 2000 FY | 34.94 Million USD | 3.69% |
| 1999 Q3 | 8.6 Million USD | 4.88% |
| 1999 Q1 | 7.5 Million USD | 2.74% |
| 1999 Q4 | 9.4 Million USD | 9.3% |
| 1999 Q2 | 8.2 Million USD | 9.33% |
| 1999 FY | 33.7 Million USD | 17.01% |
| 1998 Q3 | 7.1 Million USD | -5.33% |
| 1998 Q2 | 7.5 Million USD | 8.7% |
| 1998 Q1 | 6.9 Million USD | 1.47% |
| 1998 Q4 | 7.3 Million USD | 2.82% |
| 1998 FY | 28.8 Million USD | 12.94% |
| 1997 FY | 25.5 Million USD | 8.05% |
| 1997 Q1 | 5.8 Million USD | -4.92% |
| 1997 Q4 | 6.8 Million USD | 7.94% |
| 1997 Q3 | 6.3 Million USD | -4.55% |
| 1997 Q2 | 6.6 Million USD | 13.79% |
| 1996 Q2 | 5.9 Million USD | 3.51% |
| 1996 FY | 23.6 Million USD | 22.28% |
| 1996 Q3 | 5.9 Million USD | 0.0% |
| 1996 Q4 | 6.1 Million USD | 3.39% |
| 1996 Q1 | 5.7 Million USD | 21.28% |
| 1995 FY | 19.3 Million USD | 21.38% |
| 1995 Q4 | 4.7 Million USD | -12.96% |
| 1995 Q3 | 5.4 Million USD | 10.2% |
| 1995 Q2 | 4.9 Million USD | 13.95% |
| 1995 Q1 | 4.3 Million USD | 10.26% |
| 1994 Q4 | 3.9 Million USD | 2.63% |
| 1994 FY | 15.9 Million USD | 21.37% |
| 1994 Q1 | 3.9 Million USD | 8.33% |
| 1994 Q2 | 4.2 Million USD | 7.69% |
| 1994 Q3 | 3.8 Million USD | -9.52% |
| 1993 Q2 | 3.1 Million USD | -6.06% |
| 1993 FY | 13.1 Million USD | 21.3% |
| 1993 Q1 | 3.3 Million USD | 13.79% |
| 1993 Q4 | 3.6 Million USD | 16.13% |
| 1993 Q3 | 3.1 Million USD | 0.0% |
| 1992 Q2 | 2.8 Million USD | 16.67% |
| 1992 Q1 | 2.4 Million USD | 4.35% |
| 1992 Q3 | 2.6 Million USD | -7.14% |
| 1992 FY | 10.8 Million USD | 61.19% |
| 1992 Q4 | 2.9 Million USD | 11.54% |
| 1991 FY | 6.7 Million USD | 179.17% |
| 1991 Q1 | 2 Million USD | 17.65% |
| 1991 Q3 | 1.6 Million USD | -30.43% |
| 1991 Q4 | 2.3 Million USD | 43.75% |
| 1991 Q2 | 2.3 Million USD | 15.0% |
| 1990 Q1 | 600 Thousand USD | 100.0% |
| 1990 Q3 | 1.2 Million USD | 33.33% |
| 1990 Q4 | 1.7 Million USD | 41.67% |
| 1990 FY | 2.4 Million USD | 900.0% |
| 1990 Q2 | 900 Thousand USD | 50.0% |
| 1989 FY | -300 Thousand USD | 0.0% |
| 1989 Q4 | 300 Thousand USD | -25.0% |
| 1989 Q3 | 400 Thousand USD | 0.0% |
| 1989 Q1 | 400 Thousand USD | 0.0% |
| 1989 Q2 | 400 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -936.981% |
| AngioDynamics, Inc. | 154.69 Million USD | -277.427% |
| AtriCure, Inc. | 300.37 Million USD | -94.384% |
| Avinger, Inc. | 2 Million USD | -29049.875% |
| Azenta, Inc. | 263.14 Million USD | -121.886% |
| BioLife Solutions, Inc. | 46.75 Million USD | -1148.871% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 75.238% |
| Daxor Corporation | 1.1 Million USD | -52813.797% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -6331.017% |
| Femasys Inc. | 691.9 Thousand USD | -84286.639% |
| GlucoTrack, Inc. | -13 Thousand USD | 4491423.077% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -859.274% |
| Hologic, Inc. | 2.22 Billion USD | 73.792% |
| ICU Medical, Inc. | 739.87 Million USD | 21.085% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 87.655% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -3394.506% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -359.564% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 489395.98% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 489395.98% |
| Masimo Corporation | 1 Billion USD | 41.816% |
| Microbot Medical Inc. | -106 Thousand USD | 550922.642% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -1664.23% |
| Nephros, Inc. | 8.4 Million USD | -6846.722% |
| NovoCure Limited | 381.05 Million USD | -53.224% |
| NEXGEL, Inc. | 619 Thousand USD | -94225.04% |
| NEXGEL, Inc. | 619 Thousand USD | -94225.04% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 104736.559% |
| OraSure Technologies, Inc. | 179.42 Million USD | -225.42% |
| Pro-Dex, Inc. | 14.55 Million USD | -3912.59% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 48473.819% |
| Predictive Oncology Inc. | 1.14 Million USD | -50879.964% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -9970.618% |
| QuidelOrtho Corporation | 1.49 Billion USD | 60.929% |
| Repligen Corporation | 315.22 Million USD | -85.222% |
| Sanara MedTech Inc. | 57.13 Million USD | -921.878% |
| STAAR Surgical Company | 252.65 Million USD | -131.098% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 65611.732% |
| Utah Medical Products, Inc. | 30.03 Million USD | -1843.778% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 72.01% |
| Jin Medical International Ltd. | 6.78 Million USD | -8505.546% |